Literature DB >> 8885139

The effect of cholesterol oxidation products on human platelet aggregation.

M L Selley1, J A McGuiness, N G Ardlie.   

Abstract

The cholesterol oxidation products (oxysterols) cholest-3,5-diene-7-one, cholestan-5 alpha, 6 alpha-epoxy-3 beta-ol (cholesterol 5 alpha-epoxide), cholestan-5 beta, 6 beta-epoxy-3 beta-ol (cholesterol 5 beta-epoxide), cholest-5-ene-3 beta-ol-7-one (7-ketocholesterol), cholest-5-ene-3 beta, 7 alpha-diol (7 alpha-hydroxycholesterol), cholestan-3 beta, 5 alpha, 6 beta-triol (cholestane triol), and cholest-5-ene-3 beta, 26-diol (27-hydroxycholesterol) potentiated platelet aggregation and increased thromboxane A2 formation in platelets challenged with thrombin, ADP or collagen. These effects were observed at oxysterol concentrations in the range 5-100 microM. Cholesterol 5 beta-epoxide and 7-ketocholesterol increased the mobilization of 3H-arachidonic acid from prelabelled platelet phospholipids in response to thrombin and collagen.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8885139     DOI: 10.1016/0049-3848(96)00154-5

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

Review 1.  Cholesterol, reactive oxygen species, and the formation of biologically active mediators.

Authors:  Robert C Murphy; Kyle M Johnson
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

Review 2.  Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins.

Authors:  Nans Florens; Catherine Calzada; Egor Lyasko; Laurent Juillard; Christophe O Soulage
Journal:  Toxins (Basel)       Date:  2016-12-16       Impact factor: 4.546

3.  Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated Platelets.

Authors:  Amanda J Unsworth; Alexander P Bye; Dionne S Tannetta; Michael J R Desborough; Neline Kriek; Tanya Sage; Harriet E Allan; Marilena Crescente; Parveen Yaqoob; Timothy D Warner; Chris I Jones; Jonathan M Gibbins
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06-15       Impact factor: 8.311

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.